Arrhythmias Detection in a Real World Population
Key facts
- Who runs it
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Where
- Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia, Pisa, and Rome, ItalySee the 12 sites
- Trial code
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- Sept 2014
- Expected to end
- Dec 2028
- Type of study
- Observational
- Treatments tested
- implantable cardioverter defibrillator
- Record updated
- 8 July 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patient implanted with a Subcutaneous (S)- Ventricular Chamber (VR)- Dual Chamber (DR) - or Cardiac Resynchronization Therapy (CRT) Defibrillator (this study will utilize all the market released CRT-D or VR/DR-ICD systems and leads)
- Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
- Patient must be able to attend all required follow-up visits at the study center for at least 12 months
Who cannot take part
- Patient is participating in another clinical study that may have an impact on the study endpoints
- Women who are pregnant or plan to become pregnant
Where in Italy
- Ospedale Papa Giovanni XXIIIBergamo, ItalyContact: Paolo De FilippoTaking people
- Policlinico S. Orsola MalpighiBologna, ItalyContact: Mauro BiffiTaking people
- P.O. Rodolico-San MarcoCatania, ItalyContact: Valeria CalviTaking people
- Azienda Ospedaliero-Universitaria CareggiFlorence, ItalyContact: Paolo PieragnoliTaking people
- ASST Rhodense- Ospedale di RhoMilan, ItalyContact: Gianluca BottoTaking people
- IRCCS S.Ambrogio-GaleazziMilan, ItalyContact: Luca OttavianoTaking people
- Ospedale dei Colli MonaldiNaples, ItalyContact: Valter BianchiTaking people
- University of PaduaPadua, ItalyContact: Federico MiglioreTaking people
- IRCC Policlinico San MatteoPavia, ItalyContact: Alessandro Vicentini, MDTaking people
- Azienda Ospedaliero Universitaria Pisa CisanelloPisa, ItalyContact: Stefano VianiTaking people
- Azienda Ospedaliera S.AndreaRome, ItalyContact: Pietro FranciaTaking people
- Ospedale Bambino gesuRome, ItalyContact: Massimo SilvettiTaking people
About the trial
What the trial wants to find out
The study is a prospective multicenter registry. Consecutive patients with indications of implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be enrolled.
Read full original descriptionShow less
The primary objective of the study is to determine the predictors of appropriate anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with an ICD.
Secondary objectives of the study are:
* the incidence of anti-tachycardia therapies; * the predictors of inappropriate therapy and onset of arrhythmia burden; * the adherence to the current guidelines in the Italian clinical practice; * the predictors of heart failure (HF) onset and response to cardiac resynchronization therapy (CRT).
Treatments tested
- implantable cardioverter defibrillator
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Arrhythmias Detection in a Real World Population: the RHYTHM DETECT Registry
- Publications
- Record updated
- 8 July 2025